185 related articles for article (PubMed ID: 11887820)
21. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
[TBL] [Abstract][Full Text] [Related]
22. Treatment of peritoneal dialysis related peritonitis.
Johnson DW; Looke D; Sturtevant JM
Aust N Z J Med; 2000 Feb; 30(1):97-8. PubMed ID: 10800893
[No Abstract] [Full Text] [Related]
23. Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.
Fielding RE; Clemenger M; Goldberg L; Brown EA
Perit Dial Int; 2002; 22(3):345-9. PubMed ID: 12227392
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
25. Campylobacter fetus peritonitis followed by septicaemia in a patient on continuous ambulatory peritoneal dialysis.
Wens R; Dratwa M; Potvliege C; Hansen W; Tielemans C; Collart F
J Infect; 1985 May; 10(3):249-51. PubMed ID: 4031516
[TBL] [Abstract][Full Text] [Related]
26. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
Bowley JA; Pickering SJ; Scantlebury AJ; Ackrill P; Jones DM
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():133-9. PubMed ID: 2965125
[TBL] [Abstract][Full Text] [Related]
27. Ambulatory peritonitis.
Lancet; 1982 May; 1(8281):1104-5. PubMed ID: 6122896
[No Abstract] [Full Text] [Related]
28. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
29. [Peritonitis in renal failure patients treated by continuous ambulatory peritoneal dialysis. Treatment by intraperitoneal administration of a group M penicillin].
Pierre D; Barthez JP; Geslin N; Calamy G; Borderon E
Presse Med; 1985 Jun; 14(26):1413-6. PubMed ID: 3161046
[TBL] [Abstract][Full Text] [Related]
30. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.
Ariano RE; Franczuk C; Fine A; Harding GK; Zelenitsky SA
Perit Dial Int; 2002; 22(3):335-8. PubMed ID: 12227390
[TBL] [Abstract][Full Text] [Related]
31. Peritonitis in continuous ambulatory peritoneal dialysis.
Gokal R
J Antimicrob Chemother; 1982 Jun; 9(6):417-20. PubMed ID: 7107547
[No Abstract] [Full Text] [Related]
32. The use of intraperitoneal antibiotics to treat dialysis-associated peritonitis.
Washington TG; Eggleston M
Infect Control; 1988 Jan; 9(1):37-9. PubMed ID: 3276641
[No Abstract] [Full Text] [Related]
33. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
34. Peritonitis in children receiving continuous ambulatory peritoneal dialysis.
McClung MR
Pediatr Infect Dis; 1983; 2(4):328-32. PubMed ID: 6889164
[No Abstract] [Full Text] [Related]
35. [Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis].
Ryckelynck JP; Debruyne D; Hurault De Ligny B; Moulin M
Pathol Biol (Paris); 1988 May; 36(5):507-10. PubMed ID: 3043348
[TBL] [Abstract][Full Text] [Related]
36. First Case Report of Peritoneal Dialysis-associated Peritonitis Caused by Lysinibacillus sphaericus.
Kinoshita T; Sahara S; Amano T; Ito M; Sakakibara T; Takimoto N; Osada Y; Oka K
Intern Med; 2023 Oct; 62(19):2919-2922. PubMed ID: 36823089
[TBL] [Abstract][Full Text] [Related]
37. The effect of peritonitis on the distribution of cefuroxime in patients undergoing continuous ambulatory peritoneal dialysis.
McIntosh ME; Smith WG; Junor BJ; Forrest G; Brodie MJ
Scott Med J; 1984 Apr; 29(2):117-8. PubMed ID: 6531683
[No Abstract] [Full Text] [Related]
38. Mixed organism peritonitis complicating continuous ambulatory peritoneal dialysis.
O'Connor J; MacCormick DE
N Z Med J; 1982 Nov; 95(720):811-2. PubMed ID: 6961320
[No Abstract] [Full Text] [Related]
39. Laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
Fenton P
J Clin Pathol; 1982 Nov; 35(11):1181-4. PubMed ID: 6754760
[TBL] [Abstract][Full Text] [Related]
40. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
Lui SL; Cheng SW; Ng F; Ng SY; Wan KM; Yip T; Tse KC; Lam MF; Lai KN; Lo WK
Kidney Int; 2005 Nov; 68(5):2375-80. PubMed ID: 16221243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
